SOPHARMA AD (201/2023) Treasury shares
Report no 201/2023
- 04.12.2023, 14:02
- Kategoria: Biznes i finanse
- Źródło: ESPI
Sopharma AD-BG11SOSOBT18-SOPHARMA
-
-
SOPHARMA AD (200/2023) Consolidated financial report as at 30 September 2023
Report no 200/2023- 29.11.2023, 13:41
- Kategoria: Biznes i finanse
- Źródło: ESPI
-
SOPHARMA AD (198/2023) Notification on the terms and conditions for distribution of the dividend
Report no 198/2023- 24.11.2023, 11:31
- Kategoria: Biznes i finanse
- Źródło: ESPI
-
SOPHARMA AD (197/2023) Sales revenues for October 2023
Report no 197/2023- 20.11.2023, 13:02
- Kategoria: Biznes i finanse
- Źródło: ESPI
-
SOPHARMA AD (196/2023) Serbian Commission for Protection of Competition allowed deal with Pharmanova
Report no 196/2023- 07.11.2023, 13:04
- Kategoria: Biznes i finanse
- Źródło: ESPI
-
SOPHARMA AD (195/2023) Individual financial report according to IFRS as at 30 September 2023
Report no 195/2023- 30.10.2023, 13:16
- Kategoria: Biznes i finanse
- Źródło: ESPI
-
SOPHARMA AD (194/2023) Sales revenues for September 2023
Report no 194/2023- 20.10.2023, 13:12
- Kategoria: Biznes i finanse
- Źródło: ESPI
-
SOPHARMA AD (193/2023) Notification for a significant shareholding from CUPF Alianz Bulgaria
Report no 193/2023- 16.10.2023, 16:01
- Kategoria: Biznes i finanse
- Źródło: ESPI
-
SOPHARMA AD (192/2023) Optimization of the activity in foreign markets
Report no 192/2023- 16.10.2023, 14:09
- Kategoria: Biznes i finanse
- Źródło: ESPI
